Litcius/Paper detail

Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial

Atefeh Fakharian, Saghar Barati, Maryam Sadat Mirenayat, Mitra Rezaei, Sara Haseli, Pooria Torkaman, Sahar Yousefian, Alireza Dastan, Hamidreza Jamaati, Farzaneh Dastan

2021International Immunopharmacology34 citationsDOIOpen Access PDF

Topics & Concepts

AdalimumabMedicineRandomized controlled trialIntensive care unitMechanical ventilationDexamethasonePneumoniaCoronavirus disease 2019 (COVID-19)Internal medicineIntensive care medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial | Litcius